Key facts
- This page summarizes Mathai Mammen's Form 4 filing for JOHNSON & JOHNSON (JNJ).
- 5 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 17 Feb 2022, 05:00.
Mathai Mammen - 14 Feb 2022 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)
- Reporting relationship
- EVP, Pharm, R&D
- Issuer ticker
- JNJ
- Reported as of
- 14 Feb 2022
- Net transaction value
- +$5,867,529
- SEC form
- 4
- Accepted by SEC
- 17 Feb 2022, 05:00:56 UTC
- Prior SEC filing
- 13 Jan 2022
- Next SEC filing
- 17 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- Raavi Deol, as attorney-in-fact for Mathai Mammen
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Mathai Mammen filed Form 4 for JOHNSON & JOHNSON (JNJ) on 17 Feb 2022.
Change
- Previous filing in this sequence was filed on 13 Jan 2022.
- Current net transaction value: +$5,867,529.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
JNJ
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +7,740
- Change %
- +21%
- Price
- $0.000000
- Shares after
- 45,300
- Date
- 15 Feb 2022
- Ownership
- Direct
- Footnotes
- F1
JNJ
transaction
Common Stock
Tax liability
- Transaction value
- $558,386
- Shares
- -3,366
- Change %
- -7.4%
- Price
- $165.89
- Shares after
- 41,934
- Date
- 15 Feb 2022
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
JNJ
transaction
Derivative
Employee Stock Options (Right to Buy)
Award
- Transaction value
- $6,425,915
- Shares
- +38,736
- Change %
- Price
- $165.89
- Shares after
- 38,736
- Date
- 14 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 38,736
- Exercise price
- Footnotes
- F3
JNJ
transaction
Derivative
Restricted Share Units
Award
- Transaction value
- $0
- Shares
- +3,922
- Change %
- Price
- $0.000000
- Shares after
- 3,922
- Date
- 14 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,922
- Exercise price
- Footnotes
- F4
JNJ
transaction
Derivative
Performance Share Units
Options Exercise
- Transaction value
- $0
- Shares
- -7,740
- Change %
- -91%
- Price
- $0.000000
- Shares after
- 737
- Date
- 15 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,740
- Exercise price
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.
Footnote F2
Shares withheld for payment of taxes upon vesting of Performance Share Units.
Footnote F3
Awarded under Issuer's Long-Term Incentive Plan.
Footnote F4
Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant.
Footnote F5
Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited.